Publications by NDC Members

Collapse All | Expand All

• Izadyar S, Kwan JY, Gundogdu BM, Phan CL, Harati Y. Mutilating acral ulcers: the spectrum of differential diagnosis. J Clin Neuromuscul Dis. 2009;10:126-34.

Collapse All | Expand All

• Tsuda H, Han SM, Yang Y, Tong C, Lin YQ, Mohan K, Haueter C, Zoghbi A, Harati Y, Kwan J, Miller MA, Bellen HJ. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell. 2008;133:963-77.

Collapse All | Expand All

• Harati Y. Diabetic neuropathies: unanswered questions. Neurol Clin. 2007;25:303-17.

Collapse All | Expand All

• Izadyar S, Kwan JY, Harati Y. Myeloneuropathic presentation of spinal epidural lipomatosis. J Clin Neuromuscul Dis. 2006;7:133-40.

Collapse All | Expand All

• Murtagh B, Wadia Y, Messner G, Allison P, Harati Y, Delgado R. West Nile virus infection after cardiac transplantation. J Heart Lung Transplant. 2005;24:774-6.

Collapse All | Expand All

• Andersen PM, Sims KB, Xin WW, Kiely R, O'Neill G, Ravits J, Pioro E, Harati Y, Brower RD, Levine JS, Heinicke HU, Seltzer W, Boss M, Brown RH, Jr. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:62-73.
• Filosto M, Mancuso M, Nishigaki Y, Pancrudo J, Harati Y, Gooch C, Mankodi A, Bayne L, Bonilla E, Shanske S, Hirano M, DiMauro S. Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma. Arch Neurol. 2003;60:1279-84.
• Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, Mitsumoto H, Pascuzzi R, Spencer PS, Tim R, Howard D, Smith TC, Ryan MA, Coffman CJ, Kasarskis EJ. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003;61:742-9.

Collapse All | Expand All

• Bradley WG, Anderson F, Bromberg M, Gutmann L, Harati Y, Ross M, Miller RG. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology. 2001;57:500-4.
• Mendell JR, Barohn RJ, Freimer ML, Kissel JT, King W, Nagaraja HN, Rice R, Campbell WW, Donofrio PD, Jackson CE, Lewis RA, Shy M, Simpson DM, Parry GJ, Rivner MH, Thornton CA, Bromberg MB, Tandan R, Harati Y, Giuliani MJ. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2001;56:445-9.
• Gooch CL, Harati Y. Motor unit number estimation, ALS and clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:71-82.
• Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, Donofrio P, Cornblath D, Olson WH, Kamin M. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000;14:65-70.
• Nagamitsu S, Matsuura T, Khajavi M, Armstrong R, Gooch C, Harati Y, Ashizawa T. A 'dystrophic' variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene. Neurology. 2000;55:1697-703.
• Bidichandani SI, Purandare SM, Taylor EE, Gumin G, Machkhas H, Harati Y, Gibbs RA, Ashizawa T, Patel PI. Somatic sequence variation at the Friedreich ataxia locus includes complete contraction of the expanded GAA triplet repeat, significant length variation in serially passaged lymphoblasts and enhanced mutagenesis in the flanking sequence. Hum Mol Genet. 1999;8:2425-36.
• Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Kamin M. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50:1842-6.
• Machkhas H, Bidichandani SI, Patel PI, Harati Y. A mild case of Friedreich ataxia: lymphocyte and sural nerve analysis for GAA repeat length reveals somatic mosaicism. Muscle Nerve. 1998;21:390-3.
• Machkhas H, Harati Y. Side effects of immunosuppressant therapies used in neurology. Neurol Clin. 1998;16:171-88.
• Gooch CL, Harati Y. Longitudinal tracking of the same single motor unit in amyotrophic lateral sclerosis. Muscle Nerve. 1997;20:511-3.
• Shaibani A, Gooch C, Harati Y. Moving toes and myoclonus associated with hereditary neuropathy with liability to pressure palsy (HNPP). Muscle Nerve. 1997;20:881-3.
• Collard CD, Baker BW, 3rd, Johnson D, Bressler R, Harati Y. Cumulative reduction in serum cholinesterase following repeated therapeutic plasma exchange. J Clin Anesth. 1996;8:44-8.
• Dunne PW, Ma L, Casey DL, Harati Y, Epstein HF. Localization of myotonic dystrophy protein kinase in skeletal muscle and its alteration with disease. Cell Motil Cytoskeleton. 1996;33:52-63.
• Harati Y. Diabetes and the nervous system. Endocrinol Metab Clin North Am. 1996;25:325-59.
• Miller RG, Bouchard JP, Duquette P, Eisen A, Gelinas D, Harati Y, Munsat TL, Powe L, Rothstein J, Salzman P, Sufit RL. Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II. Neurology. 1996;47:S86-90; discussion S90-2.
• Siklos L, Engelhardt J, Harati Y, Smith RG, Joo F, Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann Neurol. 1996;39:203-16.
• Harati Y, Shaibani AI. Aseptic meningitis and intravenous immunoglobulin therapy. Ann Intern Med. 1995;122:316.
• Smith RG, Kimura F, Harati Y, McKinley K, Stefani E, Appel SH. Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease. Muscle Nerve. 1995;18:620-7.
• Di Monte DA, Harati Y, Jankovic J, Sandy MS, Jewell SA, Langston JW. Muscle mitochondrial ATP production in progressive supranuclear palsy. J Neurochem. 1994;62:1631-4.
• Ashizawa T, Dubel JR, Harati Y. Somatic instability of CTG repeat in myotonic dystrophy. Neurology. 1993;43:2674-8.
• McKinley KL, Harati Y, Schneider LW. Chronic immune activation in the eosinophilia-myalgia syndrome. Muscle Nerve. 1993;16:947-51.
• Berti-Mattera LN, Harati Y, Eichberg J. Decreased polyphosphoinositide metabolism accompanies myelinated fiber loss in human peripheral neuropathies. Mol Chem Neuropathol. 1992;17:201-8.
• Harati Y. Frequently asked questions about diabetic peripheral neuropathies. Neurol Clin. 1992;10:783-807.
• Rolak LA, Rutecki P, Ashizawa T, Harati Y. Clinical features of Todd's post-epileptic paralysis. J Neurol Neurosurg Psychiatry. 1992;55:63-4.
• Silver RM, McKinley K, Smith EA, Quearry B, Harati Y, Sternberg EM, Heyes MP. Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. Arthritis Rheum. 1992;35:1097-105.
• Ballantyne CM, Podet EJ, Patsch WP, Harati Y, Appel V, Gotto AM, Jr., Young JB. Effects of cyclosporine therapy on plasma lipoprotein levels. Jama. 1989;262:53-6.
• Danon MJ, Carpenter S, Harati Y. Muscle pain associated with tubular aggregates and structures resembling cylindrical spirals. Muscle Nerve. 1989;12:265-72.
• Appel SH, Stewart SS, Appel V, Harati Y, Mietlowski W, Weiss W, Belendiuk GW. A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis. Arch Neurol. 1988;45:381-6.
• Niakan E, Harati Y. Sympathetic skin response in diabetic peripheral neuropathy. Muscle Nerve. 1988;11:261-4.
• Harati Y, Niakan E, Bloom K, Casar G. Adult onset of nemaline myopathy presenting as diaphragmatic paralysis. J Neurol Neurosurg Psychiatry. 1987;50:108-10.
• Harati Y. Diabetic peripheral neuropathies. Ann Intern Med. 1987;107:546-59.
• Rosenbaum F, Harati Y, Rolak L, Freedman M. Visual hallucinations in sane people: Charles Bonnet syndrome. J Am Geriatr Soc. 1987;35:66-8.
• Harati Y, Niakan E, Bergman EW. Childhood dermatomyositis in monozygotic twins. Neurology. 1986;36:721-3.
• Harati Y, Niakan E. Clinical significance of selective nerve fascicular degeneration on sural nerve biopsy specimen. Arch Pathol Lab Med. 1986;110:195-7.
• Harati Y, Niakan E. Diabetic thoracoabdominal neuropathy. A cause for chest and abdominal pain. Arch Intern Med. 1986;146:1493-4.
• Harati Y, Niakan E. Hydrazine toxicity, pyridoxine therapy, and peripheral neuropathy. Ann Intern Med. 1986;104:728-9.
• Harati Y, Niakan E. The clinical spectrum of inflammatory-angiopathic neuropathy. J Neurol Neurosurg Psychiatry. 1986;49:1313-6.
• Kalanie H, Niakan E, Harati Y, Rolak LA. Phenytoin-induced benign intracranial hypertension. Neurology. 1986;36:443.
• Niakan E, Harati Y, Comstock JP. Diabetic autonomic neuropathy. Metabolism. 1986;35:224-34.
• Niakan E, Harati Y, Rolak LA, Comstock JP, Rokey R. Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med. 1986;146:2229-30.
• Niakan E, Harati Y, Rolak LA. Immunosuppressive drug therapy in myasthenia gravis. Arch Neurol. 1986;43:155-6.
• Harati Y, Butler IJ. Congenital hypomyelinating neuropathy. J Neurol Neurosurg Psychiatry. 1985;48:1269-76.
• Niakan E, Harati Y, Danon MJ. Tubular aggregates: their association with myalgia. J Neurol Neurosurg Psychiatry. 1985;48:882-6.
• Harati Y, Jackson JA, Benjamin E. Adult onset idiopathic familial brain calcifications. Arch Intern Med. 1984;144:2425-7.
• Harati Y, Niakan E. Thymectomy for autoimmune disease other than rheumatoid arthritis. Lancet. 1984;1:792.
• Kundu SK, Harati Y, Misra LK. Sialosylglobotetraosylceramide: a marker for amyotropic lateral sclerosis. Biochem Biophys Res Commun. 1984;118:82-9.
• Rokey R, Rolak LA, Harati Y, Kutka N, Verani MS. Coronary artery disease in patients with cerebrovascular disease: a prospective study. Ann Neurol. 1984;16:50-3.
• Ashizawa T, Butler IJ, Harati Y, Roongta SM. A dominantly inherited syndrome with continuous motor neuron discharges. Ann Neurol. 1983;13:285-90.
• Evans RW, Harati Y. What's new: review of clinical presentations, pathophysiology, and treatment of diabetic neuropathies. Tex Med. 1983;79:50-4.
• Misra LK, Kasturi SR, Kundu SK, Harati Y, Hazlewood CF, Luthra MG, Yamanashi WS, Munjaal RP, Amtey SR. Evaluation of muscle degeneration in inherited muscular dystrophy by nuclear magnetic resonance techniques. Magn Reson Imaging. 1982;1:75-9.
• Hoffman TG, Harati Y, Whitaker SH. Transient paraplegia caused by aortic occlusion. Arch Neurol. 1981;38:668-9.
• Meyer JS, Hayman LA, Amano T, Nakajima S, Shaw T, Lauzon P, Derman S, Karacan I, Harati Y. Mapping local blood flow of human brain by CT scanning during stable xenon inhalation. Stroke. 1981;12:426-36.
• Frank JP, Harati Y, Butler IJ, Nelson TE, Scott CI. Central core disease and malignant hyperthermia syndrome. Ann Neurol. 1980;7:11-7.
• Harati Y, Matta K. Gomori's trichrome stain. Arch Neurol. 1979;36:454-5.
• Harati Y, Patten BM. Prednisone use in concurrent autoimmune diseases. Arch Neurol. 1979;36:103-6.
• Patten BM, Wood JM, Harati Y, Hefferan P, Howell RR. Familial recurrent rhabdomyolysis due to carnitine palmityl transferase deficiency. Am J Med. 1979;67:167-71.
• Patten BM, Zito G, Harati Y. Histologic findings in motor neuron disease. Relation to clinically determined activity, duration, and severity of disease. Arch Neurol. 1979;36:560-4.
• Harati Y, Mitchell C. Jakob-Creutzfeldt disease: brief review and precautionary measures. Tex Med. 1978;74:52-4.
• Patten BM, Harati Y, Acosta L, Jung SS, Felmus MT. Free amino acid levels in amyotrophic lateral sclerosis. Ann Neurol. 1978;3:305-9.